National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -5 of 5         results per page
 View Search Criteria | Help With Results
           

1.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 to 70
Other
Haema CBF SCLC UK/AS 02
NCT00168922

Last Modified: 2/20/2008     First Published: 12/22/2005  

2.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Other, Pharmaceutical / Industry
GCLLSG-CLL2M
EU-20552, EUDRACT-2005-001596-34, ROCHE-GCLLSG-CLL2M, NCT00274989


3.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Other
OSHO #73
NCT00385125


4.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
C05011
NCT00636792


5.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Other
08-041
NCT00705250

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov